Highlights Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
8.34 ^CNY	+0.36%		-2.57%	-10.90%

07:08am	Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension	MT
16/05	Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension	10:38am	MT
Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops	16/05	MT
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	20/04	CI
Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 23, 2023, has closed with 11,687,200 shares, representing 0.98% for CNY 98.99 million.	18/04	CI
Hisun Pharma's Unit Gets Nod for Pig Vaccine	17/04	MT
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	02/04	CI
China Energy Engineering Issues Apology Over Former Director's Stake Disposal Breaches	27/03	MT
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	03/01	CI
Zhejiang Hisun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	23/12	CI
Zhejiang Hisun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	22/12	CI
Hisun Pharmaceutical's Unit Gets Certification for Imported Drug from Pfizer	15/12	MT
Hisun Pharmaceutical's Unit Gets Import Drug Certificate for Methylprednisolone Tablets	29/11	MT
Hisun Pharmaceutical's Unit Gets Nod for Carprofen Tablets for Dogs	29/11	MT
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Hisun Pharmaceutical Gets China Nod to Market Cytarabine	11/23/11	MT
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.	21/23/21	CI
Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 22, 2022, has closed with 18,489,100 shares, representing 1.55% for CNY 194.73 million.	20/23/20	CI
Shanghai Shyndec Pharma Gets Nod to Market Blood Sugar Drug Ingredient	14/23/14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Highlights

Filters